Becton Dickinson closes TriPath deal
This article was originally published in Clinica
Becton Dickinson (BD) has completed its acquisition of TriPath Imaging after the latter's shareholders approved the deal. BD paid about $350m for the 93.5% of shares in the Burlington, North Carolina cancer detection firm it did not already own. The deal was completed on schedule on December 20.